290 results on '"Bednarski, Jeffrey J."'
Search Results
2. Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium study
3. Pediatric Necrobiotic Xanthogranuloma as a Novel Phenotype of IKAROS Gain of Function
4. MYSM1 attenuates DNA damage signals triggered by physiologic and genotoxic DNA breaks
5. A Case of Severe Combined Immunodeficiency Missed by Newborn Screening
6. Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study
7. Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function
8. Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD
9. Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers.
10. Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium
11. Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey.
12. The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions
13. Erratum for Franco et al., “A Novel Secreted Protein, MYR1, Is Central to Toxoplasma’s Manipulation of Host Cells”
14. Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC
15. Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant
16. Cutting Edge: The Tetraspanin CD53 Promotes CXCR4 Signaling and Bone Marrow Homing in B Cells
17. Outcomes Following Matched Sibling Donor Transplant for Severe Combined Immunodeficiency: A Report from the Pidtc
18. Donor-Derived Memory-like NK Cells for the Treatment of Children and Young Adults with Relapsed AML Following Allo-HCT
19. Assessing DNA Damage Responses Using B Lymphocyte Cultures
20. Novel EXTL3 Variants Causing Neuro-Immuno-Skeletal Dysplasia.
21. A Novel CYBB Variant Causing X-Linked Chronic Granulomatous Disease in a Patient with Empyema
22. A Novel Secreted Protein, MYR1, Is Central to Toxoplasma’s Manipulation of Host Cells
23. Pediatric Necrobiotic Xanthogranuloma as a Novel Phenotype of IKAROS Gain of Function
24. MYSM1 attenuates DNA damage signals triggered by physiologic and genotoxic DNA breaks
25. The SMC5/6 complex is required for maintenance of genome integrity upon APOBEC3A-mediated replication stress
26. Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic Lymphohistiocytosis
27. Correction to: Infections in Infants with SCID: Isolation, Infection Screening and Prophylaxis in PIDTC Centers
28. Recovery from COVID-19 in a Child with Chronic Granulomatous Disease and T Cell Lymphopenia
29. Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study
30. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery
31. Safety of Probiotics Among High-Risk Pediatric Hematopoietic Stem Cell Transplant Recipients
32. At the intersection of DNA damage and immune responses
33. Brief IL-12, IL-15, IL-18 activation drives the acquisition of two distinct memory-like NK cell states
34. DNA double-strand breaks induce H2Ax phosphorylation domains in a contact-dependent manner
35. Event Free Survival in Severe Combined Immune Deficiency (SCID) Infants after Conditioned Umbilical Cord Blood Transplantation (UCBT) Benefits from Omitting Serotherapy
36. Attaining Therapeutic Busulfan Pharmacokinetic Ranges Utilizing a Busulfan Nomogram without Adverse Effects on Organ Systems and Survival: One Institution’s Experience
37. Allogenic Hematopoietic Cell Transplantations Are Effective in Patients with p47phox Chronic Granulomatous Disease: A Primary Immune Deficiency Treatment Consortium Study
38. Hematopoietic KIT D816Y mutation presenting as in utero aggressive systemic mastocytosis with response to midostaurin
39. Nuclease‐independent functions of RAG1 direct distinct DNA damage responses in B cells
40. BCLAF1 Regulates Expression of AP-1 Genes and Fetal Hematopoietic Stem Cell Repopulation Activity
41. DNA Damage Signals Repress SYK in Early B Cells to Limit Leukemic Transformation
42. Hematopoietic KIT D816Y mutation presenting as in utero aggressive systemic mastocytosis with response to midostaurin
43. 116 - Event Free Survival in Severe Combined Immune Deficiency (SCID) Infants after Conditioned Umbilical Cord Blood Transplantation (UCBT) Benefits from Omitting Serotherapy
44. Hematology and Oncology
45. Bclaf1 promotes hematopoietic stem cell repopulating capacity and self-renewal
46. Omenn Syndrome Presenting with Striking Erythroderma and Extreme Lymphocytosis in a Newborn
47. Ataxia telangiectasia mutated (Atm) and DNA-PKcs kinases have overlapping activities during chromosomal signal joint formation
48. Cytokine-Induced Memory-like NK Cells Have a Distinct Single Cell Transcriptional Profile and Persist for Months in Adult and Pediatric Leukemia Patients after Adoptive Transfer
49. Maternal T-Cell Engraftment Interferes With Human Leukocyte Antigen Typing in Severe Combined Immunodeficiency
50. Nuclease‐independent functions of RAG1 direct distinct DNA damage responses in B cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.